Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
暂无分享,去创建一个
Andrew King | Isidro Ferrer | Istvan Bodi | Christine Stadelmann | Thomas Arzberger | Safa Al-Sarraj | Irina Alafuzoff | Ellen Gelpi | Giorgio Giaccone | Paul Ince | Danielle Seilhean | Fabrizio Tagliavini | H. Braak | I. Ferrer | S. Al-Sarraj | M. Graeber | W. Kamphorst | I. Alafuzoff | N. Bogdanovic | H. Kretzschmar | T. Arzberger | C. Stadelmann | F. Tagliavini | P. Korkolopoulou | E. Patsouris | S. Wharton | P. Ince | O. Bugiani | D. Thal | A. King | D. Seilhean | I. Bodi | E. Gelpí | G. Kovacs | Piero Parchi | W. Roggendorf | C. Monoranu | Heiko Braak | Hans Kretzschmar | Nenad Bogdanovic | Orso Bugiani | Penelope Korkolopoulou | David Meyronet | Camelia Monoranu | Piero Parchi | Efstratios Patsouris | Nathalie Streichenberger | Dietmar R Thal | Wolfgang Roggendorf | G. Giaccone | D. Meyronet | Sergey Larionov | Kelly Del-Tredici | Manuel B Graeber | Wouter Kamphorst | Gábor G Kovács | Stephen B Wharton | N. Streichenberger | S. Larionov | Kelly Del-Tredici
[1] H. Braak,et al. Two Types of Sporadic Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.
[2] John Q. Trojanowski,et al. Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[3] R. Ferner. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective , 2007, The Lancet Neurology.
[4] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[5] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[6] Majaz Moonis,et al. Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees , 2007, The Journal of Neuroscience.
[7] C. Filley. Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.
[8] I. Ferrer,et al. Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.
[9] B. Crain,et al. Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Journal of neuropathology and experimental neurology.
[10] H. Braak,et al. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria , 1998, Journal of Neural Transmission.
[11] W. Schlote,et al. Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories A European multicenter study under the auspices of EURAGE , 1990, Journal of the Neurological Sciences.
[12] J. Trojanowski,et al. Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[13] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[14] Sudha Seshadri,et al. Visual Association Pathology in Preclinical Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.
[15] M. Roth,et al. Observations on the brains of non-demented old people. , 1968, Journal of the neurological sciences.
[16] A. Heyman,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.
[17] Alistair Burns,et al. Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .
[18] L. Thal,et al. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. , 2000, Archives of neurology.
[19] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[20] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[21] I. Alafuzoff,et al. α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.
[22] H. Braak,et al. Staging of Alzheimer-type pathology: an interrater-intrarater study. , 1997, Dementia and geriatric cognitive disorders.
[23] D. Graham,et al. Global democratic consensus on neuropathological disease criteria , 2002, The Lancet Neurology.
[24] Dennis W. Dickson,et al. Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.